Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis

Clinical and Experimental Immunology

Volumn 128, Issue 2, 2002, Pages 245-254

  Nygardas P T ^a,b   Hinkkanen, A E ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

BALB c mouse; Experimental autoimmune encephalomyelitis; Matrix metalloproteinases; Sonicated adjuvant; Tissue inhibitors of matrix metalloproteinases

Indexed keywords

ANTIGEN; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOLOGICAL ADJUVANT; MESSENGER RNA; NEUTROPHIL COLLAGENASE; PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GENE EXPRESSION; IMMUNIZATION; MENINX; MOUSE; MOUSE STRAIN; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROVOCATION TEST; REGULATORY MECHANISM; SPINAL CORD; STAINING; TH2 CELL; TREATMENT PLANNING; ULTRASOUND;

EID: 0036096968     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01855.x     Document Type: Article

References (47)

1. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution
2. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions
3. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions
4. Plasminogen activators and matrix metalloproteinases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system
5. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein
6. Matrix metálloproteinases degrade myelin basic protein
7. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein
8. Matrix metalloproteinases in immunity
9. Processing of tumor necrosis factor-alpha precursor by metalloproteinases
10. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing
11. Expression of metallo-proteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells
12. Quantitation of matrix metallo-proteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard
13. Human T lymphocytes express a member of the matrix metalloproteinase gene family
14. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development
15. White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues
16. Human skin fibroblast collagenase inhibitor
17. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor
18. Human 72 kDa type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2
19. Growth promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells: A possible new growth factor in serum
20. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
21. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3
22. Antigen localization regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity
23. Physical state of the neuroantigen in adjuvant emulsions determines encephalitogenic status in the BALB/c mouse
24. Enhancement of experimental autoimmune encephalomyelitis severity by ultrasound emulsification of antigen/adjuvant in distinct strains of mice
25. Neutrophils secreting tumor necrosis factor alpha infiltrate the central nervous system of BALB/c mice with experimental autoimmune encephalomyelitis
26. Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse
27. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis
28. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumor necrosis factor-alpha inhibitor
29. Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse
30. Matrix metalloproteinase-9 (mmp-9) in human cerebrospinal fluid (CSF): Elevated levels are primarily related to CSF cell count
31. Treatment of murine experimental autoimmune encephalomyelitis with a myelin basic protein peptide analog alters the cellular composition of leukocytes infiltrating the cerebrospinal fluid
32. Early eosinophil infiltration into the optic nerve of mice with experimental allergic encephalomyelitis
33. Myelin oligodendrocyte glyco-protein induces experimental autoimmune encephalomyelitis in the 'resistant' Brown Norway rat: Disease susceptibility is determined by MHC and MHC-linked effects on the B cell response
34. Matrix metalloproteinase expression in an experimentally induced DTH model of multiple sclerosis in the rat CNS
35. Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro
36. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8
37. The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization
38. Neutrophil gelatinase B potentiates interleukin-8 tenfold by amino-terminal processing, whereas it degrades CTAP-III, PF-4 and GRO-a and leaves RANTES and MCP-2 intact
39. RNase protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs
40. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
41. Multiple sclerosis. pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta
42. Tissue inhibitor of metalloproteinase (TIMP-2)
43. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester
44. Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to pro-inflammatory cytokines
45. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790
46. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metallo-proteinases
47. Reversal of experimental auto-immune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases